Cargando…

39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS

BACKGROUND: A dysregulated immune system is implicated in the development of psychotic disorders. Persons with schizophrenia have altered levels of circulating immune cell signaling molecules (cytokines), and elevation of specific cytokines predict conversion to psychosis in persons at clinical high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perkins, Diana, Clark, Jeffries, Addington, Jean, Beardon, Carrie, Cadenhead, Kristin, Cannon, Tyrone, Cornblatt, Barbara, Mathalon, Daniel, McGlashan, Thomas, Seidman, Larry, Tsuang, Ming, Walker, Elaine, Woods, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887597/ http://dx.doi.org/10.1093/schbul/sby014.159

Ejemplares similares

T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Worthington, Michelle, et al.
Publicado: (2020)

S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING
por: Allswede, Dana, et al.
Publicado: (2018)

Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project
por: Perkins, Diana O., et al.
Publicado: (2015)

S184. MACHINE LEARNING REVEALS DEVIANCE IN NEUROANATOMICAL MATURITY PREDICTIVE OF FUTURE PSYCHOSIS IN YOUTH AT CLINICAL HIGH RISK
por: Chung, Yoonho, et al.
Publicado: (2018)

O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT
por: Cullen, Alexis, et al.
Publicado: (2018)

Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis
por: Deng, Wisteria, et al.
Publicado: (2021)

24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1
por: Velthorst, Eva, et al.
Publicado: (2018)

Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort
por: Cullen, Alexis E., et al.
Publicado: (2020)

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis
por: Collins, Meghan A., et al.
Publicado: (2021)

Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
por: Buchy, Lisa, et al.
Publicado: (2015)

F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2)
por: Santesteban-Echarri, Olga, et al.
Publicado: (2018)

Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort
por: Barbato, Mariapaola, et al.
Publicado: (2015)

O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY
por: Hamilton, Holly, et al.
Publicado: (2020)

Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort
por: Chung, Yoonho, et al.
Publicado: (2019)

O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS
por: Woodberry, Kristen, et al.
Publicado: (2018)

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis
por: Devoe, Daniel J., et al.
Publicado: (2023)

Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes
por: Deng, Wisteria, et al.
Publicado: (2023)

O3.2. BRAIN HYPERACTIVATION DURING MEMORY RETRIEVAL PRECEDES AND PREDICTS CONVERSION TO PSYCHOSIS IN INDIVIDUALS AT CLINICAL HIGH RISK
por: Cao, Hengyi, et al.
Publicado: (2018)

Insights into psychosis risk from leukocyte microRNA expression
por: Jeffries, C D, et al.
Publicado: (2016)

Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status
por: Tran, Tanya, et al.
Publicado: (2023)

F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
por: Foss-Feig, Jennifer, et al.
Publicado: (2018)

Networks of blood proteins in the neuroimmunology of schizophrenia
por: Jeffries, Clark D., et al.
Publicado: (2018)

Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm
por: Cadenhead, Kristin S., et al.
Publicado: (2020)

Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD
por: Olde Loohuis, Loes M., et al.
Publicado: (2021)

Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study
por: Foss-Feig, Jennifer H., et al.
Publicado: (2021)

O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT
por: Di Biase, Maria, et al.
Publicado: (2020)

The association between area-level residential instability and gray matter volume changes
por: Ku, B., et al.
Publicado: (2022)

Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization
por: Cao, Hengyi, et al.
Publicado: (2018)

Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis
por: Amir, Carolyn M., et al.
Publicado: (2023)

Stability of mismatch negativity event‐related potentials in a multisite study
por: Roach, Brian J., et al.
Publicado: (2020)

Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk
por: Collins, Meghan A., et al.
Publicado: (2022)

The Mini-SIPS: development of a brief clinical structured interview guide to diagnosing DSM-5 Attenuated Psychosis Syndrome and training outcomes
por: Woods, Scott W., et al.
Publicado: (2022)

Cognitive-Behavioral Social Skills Training: Outcome of a Randomized Controlled Trial for Youth at Risk of Psychosis
por: Addington, Jean, et al.
Publicado: (2023)

Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis
por: Fryer, Susanna L., et al.
Publicado: (2013)

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate
por: Shrivastava, Amresh, et al.
Publicado: (2011)

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study
por: Srihari, Vinod H, et al.
Publicado: (2014)

21.3 NEUROIMAGING MARKERS OF RISK FOR AND PROGRESSION TO FULL PSYCHOSIS IN THE NAPLS PROJECT
por: Cannon, Tyrone
Publicado: (2018)

Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study
por: Joa, Inge, et al.
Publicado: (2015)

A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale
por: Keefe, Richard S. E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g2ctijkd8lkb7tsmd54gtj28eo